We are live on ! Find out more
AF

Avanza Fonder Portfolio holdings

AUM $4.59B
1-Year Est. Return 41.03%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+41.03%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.94B
AUM Growth
+$86.8M
Cap. Flow
-$15.7M
Cap. Flow %
-0.4%
Top 10 Hldgs %
39.36%
Holding
529
New
101
Increased
162
Reduced
70
Closed
32

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$82.7M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$35M
3
JPM icon
JPMorgan Chase
JPM
+$28.6M
4
LLY icon
Eli Lilly
LLY
+$27.6M
5
AXON
Axon Enterprise
AXON
+$11.5M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$153M
2
AAPL icon
Apple
AAPL
+$128M
3
AMZN icon
Amazon
AMZN
+$42.2M
4
TSLA icon
Tesla
TSLA
+$38.8M
5
GEV icon
GE Vernova
GEV
+$13.8M

Sector Composition

Rank Sector Weight
1 Technology 34.22%
2 Financials 14.23%
3 Consumer Discretionary 12.14%
4 Communication Services 11.6%
5 Healthcare 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
26
Abbott
ABT
$187B
$24.5M 0.62%
195,451
+16,161
+9% +$2.06M
ISRG icon
27
Intuitive Surgical
ISRG
$127B
$23.4M 0.59%
41,241
+191
+0.5% +$102K
PEP icon
28
PepsiCo
PEP
$196B
$22.7M 0.58%
158,084
+9,431
+6% +$1.39M
LIN icon
29
Linde
LIN
$236B
$22.6M 0.57%
53,081
+4,708
+10% +$2.02M
RY icon
30
Royal Bank of Canada
RY
$287B
$21.9M 0.55%
93,431
+559
+0.6% +$85.8K
UNH icon
31
UnitedHealth
UNH
$382B
$21.6M 0.55%
65,502
+1,648
+3% +$558K
AMGN icon
32
Amgen
AMGN
$209B
$21.1M 0.53%
64,357
+7,150
+12% +$2.27M
LRCX icon
33
Lam Research
LRCX
$316B
$19.6M 0.5%
114,313
-4,152
-4% -$646K
ORCL icon
34
Oracle
ORCL
$339B
$19.2M 0.49%
98,654
-6,173
-6% -$1.47M
GS icon
35
Goldman Sachs
GS
$289B
$19.1M 0.49%
21,766
-929
-4% -$758K
AMAT icon
36
Applied Materials
AMAT
$347B
$18.9M 0.48%
73,646
-4,411
-6% -$1.06M
IBM icon
37
IBM
IBM
$213B
$18.8M 0.48%
63,322
+2,290
+4% +$686K
QCOM icon
38
Qualcomm
QCOM
$164B
$18.3M 0.46%
106,766
-68
-0.1% -$11.7K
TJX icon
39
TJX Companies
TJX
$179B
$17.6M 0.45%
114,629
+418
+0.4% +$61.8K
TMO icon
40
Thermo Fisher Scientific
TMO
$214B
$17.5M 0.45%
30,285
+1,481
+5% +$838K
BSX icon
41
Boston Scientific
BSX
$68.4B
$17.4M 0.44%
182,979
+21,210
+13% +$2.08M
CRM icon
42
Salesforce
CRM
$154B
$16.2M 0.41%
61,144
-4,894
-7% -$1.22M
GILD icon
43
Gilead Sciences
GILD
$165B
$16.1M 0.41%
130,929
+3,890
+3% +$473K
MS icon
44
Morgan Stanley
MS
$319B
$15.8M 0.4%
88,892
-138
-0.2% -$23K
AXP icon
45
American Express
AXP
$224B
$15.5M 0.39%
41,782
+1,898
+5% +$679K
C icon
46
Citigroup
C
$213B
$15.4M 0.39%
132,034
-4,738
-3% -$492K
SYK icon
47
Stryker
SYK
$135B
$14.9M 0.38%
42,319
+3,117
+8% +$1.14M
KLAC icon
48
KLA
KLAC
$222B
$14.8M 0.38%
121,940
-760
-0.6% -$89.1K
DIS icon
49
Walt Disney
DIS
$171B
$14.7M 0.37%
129,419
– –
PFE icon
50
Pfizer
PFE
$143B
$14.6M 0.37%
585,928
+7,290
+1% +$184K
1
2
3 4 5

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return

Avanza Fonder's Q4 2025 Portfolio in Review

As of Q4 2025, Avanza Fonder held 529 positions worth $3.94B, up 2.2% from $3.86B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Avanza Fonder's Q4 2025 filing shows 101 new, 162 increased, 70 reduced and 32 closed positions. Its largest new stake was Broadcom: 231,260 shares worth $80M. The largest sale was NVIDIA, an estimated $153M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Avanza Fonder's largest Q4 2025 buy was Broadcom: 231,260 shares worth $80M.
  • Avanza Fonder added most to Eli Lilly in Q4 2025, an estimated $27.6M increase.
  • Avanza Fonder's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $153M.
  • Avanza Fonder fully exited Healthpeak Properties in Q4 2025, selling an estimated $1.64M.
  • Avanza Fonder's ten largest holdings make up 39% of its $3.94B portfolio in Q4 2025.
  • Avanza Fonder opened 101 new positions and closed 32 in Q4 2025.
  • Avanza Fonder's portfolio value rose 2.2% quarter-over-quarter to $3.94B.

Based on Avanza Fonder's 13F filing for Q4 2025, filed 12 Jan 2026.